Angiotensin-receptor blockade, cancer, and concerns.

Authors	Michael Böhm, Ulrich Laufs, Michael Pfreundschuh
Journal	The Lancet. Oncology (Lancet Oncol) Vol. 11 Issue 9 Pg. 818-9; author reply 821-2 (Sep 2010) ISSN: 1474-5488 [Electronic] England
PMID	20816376 (Publication Type: Comment, Letter)
Chemical References	Angiotensin II Type 1 Receptor Blockers Angiotensin-Converting Enzyme Inhibitors
Topics	Angiotensin II Type 1 Receptor Blockers (adverse effects) Angiotensin-Converting Enzyme Inhibitors (adverse effects) Clinical Trials as Topic Humans Meta-Analysis as Topic Neoplasms (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!